HOME Top Market Reports Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017

Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017

By: marketsandmarkets.com
Publishing Date: April 2013
Report Code: BT 1539

Discount on Reports  

  Speak to Analyst Enquiry Before Buying
 
purchase report
download pdf  request for customisation


Drug delivery technologies form an integral part of the pharmaceutical industry owing to their ability to enhance the availability and efficacy of drugs inside a patient’s system and extend patents to support the lifecycle management of leading drugs. Based on the route of drug administration, nine different market segments are covered in this report. These segments include drug delivery technologies for oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal routes of administration.

The oral drug delivery technologies represent the largest share (close to 40%) of the overall market, whereas pulmonary, transdermal, and injectable technologies are the high growth segments with an estimated double-digit CAGR. Increasing patient population for chronic ailments (such as diabetes, asthma and COPD), expanding non-traditional therapeutic applications, technological advancements, and the booming demand for minimally invasive drug delivery methods are the key drivers for these markets. However stringent regulatory processes and the difficulty in striking the right partnership deals remain the key challenges faced by the pharmaceutical and biotechnology companies in this market.

A growing number of companies are investing in technologies including orally disintegrating tablets (ODT), dry powder inhalers (DPIs), pen injectors, auto injectors, buccal films, nasal sprays, intraocular implants, and infusion pumps. The developments in these areas are a result of their proven technology, high dose efficacy, and their ability to offer enhanced patient convenience and compliance.

North America leads the drug delivery technologies market owing to well established healthcare infrastructure and the presence of big pharmaceutical players in this region. However, with increasing disposable income, development of healthcare infrastructure, and rising prevalence of chronic diseases, the pharmaceutical industry in the Asian region, especially in India and China, is booming. Thus, this region represents high revenue potential market for key players.

Some of the drug delivery technologies such as implantable and pulmonary are based on devices. The estimates for such technologies include the market for the device as well as the formulation it delivers. Other technologies such as controlled release and ODT make use of polymeric vehicles and hence, the market for such technologies is estimated based on the market of drugs implementing any such technology.

This report provides insights into different aspects of the market such as competitive landscape, market dynamics, regulatory environment assessment, and market share analysis. It highlights high growth segments that represent enormous opportunities for existing players and new entrants. The report also contains Porter’s analysis and value chain analysis, which will help companies take important strategic decisions.

The in-depth analysis provided in the report can help companies:

  • Take informed decision on entering the high growth segments of the DDT market
  • Take informed decision about geographic expansion
  • Derive successful marketing strategies
  • Planning strategies for efficient supply chain and operations
  • Find right partner for drug delivery technology

Customer Interested in this report also can view

  • European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017

  • North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) – Forecasts To 2017

Table Of Contents 
 
1 Introduction  (Page No. - 23)
  1.1 Key Take-Aways
  1.2 Report Description
  1.3 Markets Covered
  1.4 Stakeholders
  1.5 Research Methodology
      1.5.1 Market Size
      1.5.2 Market Share
      1.5.3 Key Data Points From Secondary Sources
      1.5.4 Key Data Points From Primary Sources
      1.5.5 Assumptions

2 Executive Summary  (Page No. - 29)

3 Market Overview  (Page No. - 34)
  3.1 Introduction
  3.2 Market Segmentation
  3.3 Market Dynamics
      3.3.1 Drivers
            3.3.1.1 Patent Cliff And Increased Competition To Increase Adoption Rate
            3.3.1.2 Improving Patient Compliance And Acceptability, An Impetus To The Market
            3.3.1.3 Increasing Focus On Pediatric And Geriatric Patients To Boost The Growth
            3.3.1.4 Increasing Incidence Of Chronic Diseases To Enhance Demand
      3.3.2 Restraints
            3.3.2.1 Drug Failures And Recalls Mar Market Growth
            3.3.2.2 Technical Barriers Restrict Growth
      3.3.3 Opportunities
            3.3.3.1 Collaborations Between Pharmaceutical Companies And Drug Delivery Firms
            3.3.3.2 Self-Administration And Home Care Drug Delivery Technology 
            3.3.3.3 Expanding Therapeutic Applications Of Drug Delivery Technology 
      3.3.4 Targeted Drug Delivery
            3.3.4.1 Passive Systems Contribute 60% To The Targeted Market
            3.3.4.2 Active Targeted Drug Delivery Has Major Applications In Cancer Therapy
            3.3.4.3 Companies Focus On Novel Targeted Drug Delivery
      3.3.5 Burning Issues
            3.3.5.1 Striking Right Partnerships
            3.3.5.2 Improving The Bioavailability Of Drugs
  3.4 Regulatory Environment
      3.4.1 Stringent Regulations For Pharmaceutical Drugs Across The Globe
            3.4.1.1 The Approval Process Is Complex, Time-Consuming, And Expensive
      3.4.2 Effect Of The U.S. Healthcare Reforms On The Drug Delivery Industry
      3.4.3 Regulations Related To The Approval Of Controlled Release Drugs
  3.5 Porter’s Five Forces Analysis
  3.6 Value Chain Analysis
  3.7 Market Share Analysis
      3.7.1 Pulmonary Drug Delivery
      3.7.2 Transdermal Drug Delivery
      3.7.3 Injectable Drug Delivery
            3.7.3.1 Conventional Injection Devices
            3.7.3.2 Self-Injection Devices
      3.7.4 Implantable Drug Delivery
      3.7.5 Other Drug Delivery Segments
 
4 Global Market, By Technology  (Page No. - 61)
  4.1 Introduction
      4.1.1 Drug Delivery Technology Market Witnessing Technological Advancements
  4.2 Opportunity Matrix
  4.3 Oral Drug Delivery Technology Market
      4.3.1 Big Pharma Companies Establishing In-House Capabilities
      4.3.2 Controlled Release
      4.3.3 Orodispersible Tablets (ODT) And Taste Masking
      4.3.4 Others
  4.4 Pulmonary Drug Delivery Technology Market
      4.4.1 Therapeutic Applications Of Pulmonary Delivery
            4.4.1.1 Application Of Pulmonary Delivery For Non-Respiratory Therapies Is A Growing Opportunity
      4.4.2 Metered Dose Inhalers (MDI)
      4.4.3 Dry Powder Inhalers (DPI)
      4.4.4 Nebulizers
  4.5 Transdermal Drug Delivery Technology Market
      4.5.1 Passive Transdermal Drug Delivery
            4.5.1.1 Matrix System
            4.5.1.2 Reservoir System
      4.5.2 Active Transdermal Drug Delivery
            4.5.2.1 Microporation
            4.5.2.2 Iontophoresis
            4.5.2.3 Others
  4.6 Injectable Drug Delivery
      4.6.1 Injectable Drug Delivery Market Witnessing Developments Related To Product Improvement
      4.6.2 Conventional Injectable Drug Delivery Technology 
            4.6.2.1 Low Manufacturing Cost And Affordable Prices: Key Driver For Conventional Injection Devices
            4.6.2.2 Fillable
            4.6.2.3 Prefilled
      4.6.3 Self-Injection Devices
            4.6.3.1 Self-Injection Devices Reduce Overall Treatment Cost
            4.6.3.2 Pen Injectors
            4.6.3.3 Needle-Free Injectors
            4.6.3.4 Auto Injectors
      4.6.4 Others
  4.7 Ocular Drug Delivery Technology Market
      4.7.1 Eye Drops
      4.7.2 Ointments And Gels
      4.7.3 Others
  4.8 Nasal Drug Delivery Technology Market
      4.8.1 Nasal Drug Delivery Preferred For Locally Acting Drugs And Delivery Of Vaccines
      4.8.2 Nasal Sprays
      4.8.3 Nasal Inhalers
      4.8.4 Nasal Drops
      4.8.5 Others
  4.9 Topical Drug Delivery Technology Market
      4.9.1 Topical Delivery Majorly Adopted For Dermatology Drugs
      4.9.2 Semi-Solid Formulations
      4.9.3 Liquid Formulations
      4.9.4 Solid Formulations
  4.10 Implantable Drug Delivery Technology Market
      4.10.1 Drug- Eluting Stents
      4.10.2 Implantable Infusion Pumps
            4.10.2.1 Implantable Infusion Pumps Largely Used For Therapies Of Chronic Ailments
      4.10.3 Contraceptive Implants
      4.10.4 Intravitreal Implants
      4.10.5 Brachytherapy Seeds
  4.11 Transmucosal Drug Delivery Technology Market
      4.11.1 Oral (Buccal And Sublingual)
      4.11.2 Others (Rectal, Vaginal)

5 Geographic Analysis  (Page No. - 143)
  5.1 Introduction
  5.2 North America
      5.2.1 Healthcare Reforms In The U.S. Will Impact The Drug Delivery Technology Market
  5.3 Europe
  5.4 Asia
      5.4.1 Booming Pharmaceutical Industry Set To Accelerate The Growth
  5.5 Rest Of The World (ROW)

6 Competitive Landscape  (Page No. - 190)
  6.1 Introduction
  6.2 Mergers & Acquisitions
  6.3 Agreements, Collaborations, Joint Ventures & Partnerships
  6.4 New Product Launch
  6.5 Other Developments

7 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*  (Page No. - 209)
  7.1 3m Company
  7.2 Alkermes, Inc.
  7.3 Aptalis Pharma, Inc.
  7.4 Baxter International, Inc.
  7.5 Becton, Dickinson And Company
  7.6 Catalent Pharma Solutions
  7.7 Cima Labs
  7.8 Dali Medical Devices
  7.9 Endo Health Solutions, Inc.
  7.10 Foamix
  7.11 Johnson & Johnson, Inc.
  7.12 Nektar Therapeutics, Inc.
  7.13 Optinose AS
  7.14 Psivida Corporation
  7.15 Skyepharma PLC
  7.16 Tapemark
  7.17 The Dow Chemical Company
  7.18 Valeant Pharmaceuticals
  7.19 Ypsomed Holding AG
  *Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies. 
 
 
List Of Tables   (118 Tables)
 
Table 1 Global Market, By Route Of Administration, 2010 – 2017 ($Billion)
Table 2 Key Drug Delivery Technology Providers & Marketer Companies
Table 3 Global Oral Drug Delivery Market, By Technology,2010 – 2017 ($Billion) 
Table 4 Oral Market, By Geography,2010 – 2017 ($Billion) 
Table 5 Controlled Release Drug Delivery Market, By Geography, 2010 – 2017 ($Billion)
Table 6 ODT & Taste-Masking Market, By Geography,2010 – 2017 ($Billion) 
Table 7 Other Oral Drug Delivery Technology Market,By Geography, 2010 – 2017 ($Billion) 
Table 8 Global Pulmonary Drug Delivery Market, By Device Type,2010 – 2017 ($Billion) 
Table 9 Pulmonary Drug Delivery Market, By Geography,2010 – 2017 ($Billion) 
Table 10 Comparative Overview Of Pulmonary Drug Delivery Devices
Table 11 Metered Dose Inhalation Market, By Geography,2010 – 2017 ($Billion) 
Table 12 Dry Powder Inhalation Market, By Geography,2010 – 2017 ($Billion) 
Table 13 Nebulizers Market, By Geography, 2010 – 2017 ($Billion)
Table 14 Global Transdermal Drug Delivery Market, By Mode Of Delivery, 2010 – 2017 ($Billion)
Table 15 Transdermal Drug Delivery Market, By Geography,2010 – 2017 ($Billion) 
Table 16 Passive Transdermal Drug Delivery Market, By Product Type, 2010 – 2017 ($Billion)
Table 17 Passive Transdermal Drug Delivery Market, By Geography, 2010 – 2017 ($Billion)
Table 18 Active Transdermal Drug Delivery Market, By Technology, 2010 – 2017 ($Million)
Table 19 Active Transdermal Drug Delivery Market, By Geography, 2010 – 2017 ($Million)
Table 20 Global Injectable Drug Delivery Market, By Product Type, 2010 – 2017 ($Billion)
Table 21 Injectable Drug Delivery Market, By Geography,2010 – 2017 ($Billion) 
Table 22 Conventional Injection Devices Market, By Product,2010 – 2017 ($Billion) 
Table 23 Conventional Injection Devices Market, By Geography,2010 – 2017 ($Billion) 
Table 24 Global Self-Injection Devices Market, By Product,2010 – 2017 ($Million) 
Table 25 Self-Injection Devices Market, By Geography,2010 – 2017 ($Million) 
Table 26 Other Injectors Market, By Geography, 2010 – 2017 ($Million)
Table 27 Global Ocular Drug Delivery Market, By Formulation,2010 – 2017 ($Billion) 
Table 28 Ocular Drug Delivery Market, By Geography,2010 – 2017 ($Billion) 
Table 29 Eye Drop Drug Delivery Market, By Geography,2010 – 2017 ($Billion) 
Table 30 Ointment & Gel Delivery Market, By Geography,2010 – 2017 ($Million) 
Table 31 Other Ocular Drug Delivery Market, By Geography,2010 – 2017 ($Million) 
Table 32 Global Nasal Drug Delivery Market, By Formulation,2010 – 2017 ($Billion) 
Table 33 Nasal Drug Delivery Market, By Geography,2010 – 2017 ($Billion) 
Table 34 Nasal Spray Market, By Geography, 2010 – 2017 ($Billion)
Table 35 Nasal Inhaler Market, By Geography, 2010 – 2017 ($Million)
Table 36 Nasal Drops Market, By Geography, 2010 – 2017 ($Million)
Table 37 Other Nasal Delivery Formulations Market, By Geography, 2010 – 2017 ($Million)
Table 38 Global Topical Drug Delivery Market, By Formulation,2010 – 2017 ($Billion) 
Table 39 Topical Drug Delivery Market, By Geography,2010 – 2017 ($Billion) 
Table 40 Semi-Solid Topical Formulation Market, By Geography,2010 – 2017 ($Billion) 
Table 41 Liquid Topical Formulation Market, By Geography,2010 – 2017 ($Million) 
Table 42 Solid Topical Formulation Market, By Geography,2010 – 2017 ($Million) 
Table 43 Global Implantable Drug Delivery Market, By Device,2010 – 2017 ($Billion) 
Table 44 Implantable Drug Delivery Market, By Geography,2010 – 2017 ($Billion) 
Table 45 Drug-Eluting Stents Market, By Geography,2010 – 2017 ($Billion) 
Table 46 Implantable Infusion Pumps Market, By Geography,2010 – 2017 ($Billion) 
Table 47 Contraceptive Implants Market, By Geography,2010 – 2017 ($Million) 
Table 48 Intravitreal Implants Market, By Geography,2010 – 2017 ($Million) 
Table 49 Brachytherapy Seeds Market, By Geography,2010 – 2017 ($Million) 
Table 50 Global Transmucosal Drug Delivery Market, By Mucosa Type, 2010 – 2017 ($Billion)
Table 51 Global Transmucosal Drug Delivery Market, By Geography, 2010 – 2017 ($Billion)
Table 52 Oral Transmucosal Drug Delivery Market, By Geography,2010 – 2017 ($Billion) 
Table 53 Other Transmucosal Drug Delivery Technology Market,By Geography, 2010 – 2017 ($Million) 
Table 54 Drug Delivery Market, By Geography, 2010 – 2017 ($Billion)
Table 55 North America: Drug Delivery Market, By Route Of Administration, 2010 – 2017 ($Billion)
Table 56 North America: Oral Market, By Technology, 2010 – 2017 ($Billion)
Table 57 North America: Pulmonary Market, By Device Type, 2010 – 2017 ($Billion)
Table 58 North America: Transdermal Market, By Mode Of Delivery, 2010 – 2017 ($Billion)
Table 59 North America: Injectable Market,By Technology, 2010 – 2017 ($Billion) 
Table 60 North America: Ocular Market,By Formulation, 2010 – 2017 ($Billion) 
Table 61 North America: Nasal Market, By Formulation, 2010 – 2017 ($Billion)
Table 62 North America: Topical Market,By Formulation, 2010 – 2017 ($Million) 
Table 63 North America: Implantable Market, By Device Type, 2010 – 2017 ($Million)
Table 64 North America: Transmucosal Market,By Mucosa Type, 2010 – 2017 ($Million) 
Table 65 Europe: Drug Delivery Technologies Market, By Route Of Administration, 2010 – 2017 ($Billion)
Table 66 Europe: Oral Market, By Technology,2010 – 2017 ($Billion) 
Table 67 Europe: Pulmonary Market, By Device Type,2010 – 2017 ($Billion) 
Table 68 Europe: Transdermal Market, By Mode Of Delivery, 2010 – 2017 ($Billion)
Table 69 Europe: Injectable Market, By Technology, 2010 – 2017 ($Million)
Table 70 Europe: Ocular Market, By Formulation,2010 – 2017 ($Million) 
Table 71 Europe: Nasal Market, By Formulation,2010 – 2017 ($Million) 
Table 72 Europe: Topical Market, By Formulation,2010 – 2017 ($Million) 
Table 73 Europe: Implantable Market, By Device Type, 2010 – 2017 ($Million)
Table 74 Europe: Transmucosal Market, By Mucosa Type, 2010 – 2017 ($Million)
Table 75 Asia: Drug Delivery Technologies Market, By Route Of Administration, 2010 – 2017 ($Billion)
Table 76 Asia: Oral Market, By Technology,2010 – 2017 ($Billion) 
Table 77 Asia: Pulmonary Market, By Device Type,2010 – 2017 ($Billion) 
Table 78 Asia: Transdermal Market, By Mode Of Delivery, 2010 – 2017 ($Billion)
Table 79 Asia: Injectable Market, By Technology,2010 – 2017 ($Million) 
Table 80 Asia: Ocular Market, By Formulation,2010 – 2017 ($Million) 
Table 81 Asia: Nasal Market, By Formulation,2010 – 2017 ($Million) 
Table 82 Asia: Topical Market, By Formulation,2010 – 2017 ($Million) 
Table 83 Asia: Implantable Market, By Device Type,2010 – 2017 ($Million) 
Table 84 Asia: Transmucosal Market, By Mucosa Type, 2010 – 2017 ($Million)
Table 85 ROW: Drug Delivery Technologies Market, By Route Of Administration, 2010 – 2017 ($Billion)
Table 86 ROW: Oral Market, By Technology,2010 – 2017 ($Billion) 
Table 87 ROW: Pulmonary Market, By Device Type,2010 – 2017 ($Billion) 
Table 88 ROW: Transdermal Market, By Technology,2010 – 2017 ($Million) 
Table 89 ROW: Injectable Market, By Technology,2010 – 2017 ($Million) 
Table 90 ROW: Ocular Market, By Formulation,2010 – 2017 ($Million) 
Table 91 ROW: Nasal Market, By Formulation,2010 – 2017 ($Million) 
Table 92 ROW: Topical Market, By Formulation,2010 – 2017 ($Million) 
Table 93 ROW: Implantable Market, By Device Type,2010 – 2017 ($Million) 
Table 94 ROW: Transmucosal Market, By Mucosa Type, 2010 – 2017 ($Million)
Table 95 Mergers & Acquisitions, 2011 –2013
Table 96 Agreements, Collaborations, Joint Ventures & Partnerships, 2011 –2013
Table 97 New Product Launch, 2010 – 2012
Table 98 Other Developments, 2010 – 2013
Table 99 3M Company: Total Revenue, By Segment, 2009 – 2011 ($Million)
Table 100 3M Company: Total Revenue, By Geography,2009 – 2011 ($Million) 
Table 101 Alkermes: Total Revenue, By Geography, 2009 – 2011 ($Million)
Table 102 Baxter International: Total Revenue, By Segment,2010 – 2012 ($Million) 
Table 103 Baxter International: Medical Products Total Revenue,2010 – 2012($Million) 
Table 104 Baxter International: Total Revenue, By Geography,2010 – 2012 ($Million) 
Table 105 Becton, Dickinson: Total Revenue, By Segment,2010 – 2012 ($Million) 
Table 106 Becton, Dickinson: Medical Division Total Revenue,By Segment, 2010 – 2012 ($Million) 
Table 107 Becton, Dickinson: Total Revenue, By Geography,2010 – 2012($Million) 
Table 108 Catalent Pharma Solutions: Total Revenue, By Segment,2009 – 2011 ($Million) 
Table 109 Teva Pharmaceutical Industries Limited: Total Revenue,By Segment, 2010 – 2012 ($Million) 
Table 110 Teva Pharmaceutical Industries Limited: Total Revenue,By Geography, 2010 – 2012 ($Million) 
Table 111 Endo Health Solutions, Inc.: Total Revenue, By Segment,2010 – 2012 ($Million) 
Table 112 Johnson & Johnson, Inc.: Total Revenue, By Segment,2010 – 2012 ($Million) 
Table 113 Johnson & Johnson, Inc.: Total Revenue, By Geography,2010 – 2012 ($Million) 
Table 114 The Dow Chemical Company: Total Revenue, By Segment,2010 – 2012 ($Million) 
Table 115 Valeant Pharmaceuticals: Total Revenue, By Geography,2010 – 2012 ($Million) 
Table 116 Ypsomed: Total Revenue, By Segment, 2009 – 2011 ($Million)
Table 117 Ypsomed: Total Revenue, By Geography, 2009 ($Million)
Table 118 Ypsomed: Total Revenue, By Geography, 2010 – 2011 ($Million)
 
 
List Of Figures   (29 Figures)
 
Figure 1 Global Market, By Route Of Administration (2012)
Figure 2 Drug Delivery Technology Market, By Geography, 2010 – 2017 ($Billion)
Figure 3 Global Market Segmentation
Figure 4 Market Dynamics
Figure 5 Porter’s Five Forces Analysis For Drug Delivery Market
Figure 6 Value Chain Analysis
Figure 7 Global Pulmonary: Market Share Analysis,By Key Player, 2012 
Figure 8 Global Transdermal: Market Share Analysis, By Key Player, 2012
Figure 9 Global Conventional Injection Devices: Market Share Analysis, By Key Player, 2012
Figure 10 Global Self-Injection Devices: Market Share Analysis,By Key Player, 2012 
Figure 11 Global Implantable Drug Delivery: Market Share Analysis,By Key Player, 2012 
Figure 12 Opportunity Matrix: Global Drug Delivery Market (2012)
Figure 13 Oral Drug Delivery Market Share (2012)
Figure 14 Key Growth Strategies, 2010 – 2013
Figure 15 3m Company: Total Revenue And R&D Expenses,2009 – 2011 ($Million) 
Figure 16 Alkermes: Total Revenue And R&D Expenditure,2009 – 2011 ($Million) 
Figure 17 Aptalis Pharma, Inc.: Total Revenue And R&D Expenses,2009 – 2011 ($Million) 
Figure 18 Baxter International: Total Revenue And R&D Expenses,2010 – 2012 ($Million) 
Figure 19 Becton, Dickinson: Total Revenue And R&D Expenditure,2010 – 2012 ($Million) 
Figure 20 Catalent Pharma Solutions: Total Revenue And R&D Expenses, 2009 – 2011 ($Million)
Figure 21 Teva Pharmaceutical Industries Limited: Total Revenue And R&D Expenses, 2010 – 2012 ($Million)
Figure 22 Endo Health Solutions, Inc.: Total Revenue And R&D Expenses, 2010 – 2012 ($Million)
Figure 23 Johnson & Johnson, Inc.: Total Revenue And R&D Expenses, 2010 – 2012 ($Million)
Figure 24 Nektar Therapeutics, Inc.: Total Revenue And R&D Expenses, 2009 – 2011 ($Million)
Figure 25 Psivida Corporation: Total Revenue, 2009 – 2011 ($Million)
Figure 26 Skyepharma Plc: Total Revenue And R&D Expenses,2009 – 2011 ($Million) 
Figure 27 The Dow Chemical Company: Total Revenue And R&D Expenses, 2010 – 2012 ($Million)
Figure 28 Valeant Pharmaceuticals: Total Revenue And R&D Expenses, 2010 – 2012 ($Million)
Figure 29 Ypsomed: Total Revenue And R&D Expenses,2009 – 2011 ($Million)

The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal. Oral drug delivery is further classified as controlled release technology, orodispersible tablets (ODT) and taste-masking technology, and other technologies (effervescent tablets and chewable tablets). Pulmonary drug delivery is divided into metered dose inhalers, dry powder inhalers, and nebulizers. Transdermal drug delivery is segmented into passive and active delivery. Injectable drug delivery is categorized as conventional injection, self-injection, and other injection devices

Ocular drug delivery is further divided into eye drops, ointments and gels and other formulations (ocular inserts and punctal plugs). Nasal drug delivery is classified as nasal sprays, inhalers drops, and others. Topical drug delivery is categorized into semi-solid, liquid and solid formulations. Implantable drug delivery is segmented as drug-eluting stents, infusion pumps, contraceptive implants, intraocular implants, and brachytherapy seeds. Transmucosal drug delivery technology market is classified as oral and other (rectal and vaginal). Oral is the largest segment, while pulmonary is the fastest-growing segment of the global market.

The major drivers of this market are patent expiries of certain blockbuster drugs, growing demand for self administration and home healthcare devices, rising incidence of chronic diseases such as cardiovascular diseases, diabetes and cancer, growing focus on pediatric and geriatric patients, and advancing technology. However, drug failures and recalls, and technical barriers will hamper the growth of this market, to a certain extent.

The global market was worth $142.5 billion in the year 2012; North America was the largest market, followed by Europe, and Asia. However, North America and Europe are likely to grow at lower CAGRs compared to the Asian market due to a certain amount of saturation in the market. The Asian market is poised to register maximum growth over the next five years, owing to the expansion of Asian economy, increase in disposable income, development of healthcare infrastructure, increasing penetration of health insurance, and rising prevalence of chronic diseases.

Key players in the market are 3M Company (U.S.), Alkermes (Ireland), Aptalis Pharma, Inc. (U.S.), Baxter International, Inc. (U.S.), Becton Dickinson & Co. (U.S.), Catalent Pharma Solutions (U.S.), The Dow Chemical Company (U.S.), Endo Pharmaceuticals (U.S.), Johnson & Johnson (U.S.), Nektar Therapeutics (U.S.), SkyePharma PLC (U.K.), and Ypsomed Holding AG (Switzerland).

GLOBAL DRUG DELIVERY MARKET SHARE, BY SEGMENT, 2012

Drug Delivery Technologies Market

Source: Annual Reports, SEC Filings, International Society of Drug Delivery Sciences and Technology, The APV (International Association for Pharmaceutical Technology), American Association of Pharmaceutical Scientists, Drug Development & Delivery Publication, ONdrugDelivery Journal, PharmaAsia Publication, PubMed, Expert Interviews, MnM Analysis

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports